My understanding is the agreements were similar to other deals in the sector. Skibinski's background is in biotech and he helped structure it. The relationship is solid and the agreements have flexibility. The university had been repeatedly approached for partnerships and they chose this group which should tell you something.
They're very tight lipped and by the book so information on financing or other developments are never disclosed. But, I haven't heard they are trying to raise money from other sources so I think the deal will get done.
News 
Market Data 
Discover 
